Episode 258
A Possible Cure for Sickle Cell Disease: Bill Morice, M.D., Ph.D.
November 2, 202315m 16s
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the recent news of a possible cure for sickle cell disease, as well as gene editing therapies and their impact on the laboratory.
Their discussion includes:
- Characteristics of sickle cell disease and current testing and treatment options.
- Advantages, challenges, and ethical considerations for gene editing tools.
- How gene therapies may impact the laboratory and the process for testing specimens.
- How the high cost of innovative therapeutics may accentuate disparities in care.
Topics
laboratory medicinehealthcareanswers from the labmayo clinic laboratorieslabmayo clinicclinicalDLMPMoricePritt